Brief: SyntheticMR Gets FDA Clearance For Use Of SyMRI On MRI Systems
June 14 (Reuters) - SyntheticMR AB (publ) SYNTH.TE :
* SYNTHETICMR RECEIVES FDA CLEARANCE FOR USE OF SYMRI® ON
MRI
SYSTEMS FROM SIEMENS HEALTHINEERS
* CLEARANCE MEANS THAT SYMRI IS NOW ALSO SUPPORTED FOR
CLINICAL
USE TOGETHER WITH MRI SYSTEMS FROM SIEMENS
Source text for Eikon: ID:nWkr9vgGdF
Further company coverage: SYNTH.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on SyntheticMR AB
See all newsSweden's SyntheticMR Q2 sales rise, loss narrows on cNeuro strength, India growth
Brief: SyntheticMR Q2 Operating Profit SEK -6.5 Million
SyntheticMR Q1 net sales fall 8% on lower OEM sales in Europe, North America
Brief: SyntheticMR Q1 Operating Profit SEK -6.3 Million
Sweden's SyntheticMR Q4 sales rise 42% yr/yr